Ertapenem Reconstitution with Lidocaine
When reconstituting ertapenem for intramuscular administration, 3.2 mL of 1% lidocaine HCl injection (without epinephrine) should be used, resulting in a concentration of approximately 280 mg/mL. 1
Proper Reconstitution Procedure
- Ertapenem must be reconstituted prior to administration when using the intramuscular route 1
- For intramuscular administration, reconstitute the contents of a 1 g vial of ertapenem with exactly 3.2 mL of 1% lidocaine HCl injection (without epinephrine) 1
- Shake the vial thoroughly to form solution, which will result in a concentration of approximately 280 mg/mL 1
- The reconstituted IM solution should be used within 1 hour after preparation 1
- After reconstitution, immediately withdraw the contents of the vial and administer by deep intramuscular injection into a large muscle mass (such as the gluteal muscles or lateral part of the thigh) 1
Important Considerations and Precautions
- The reconstituted solution with lidocaine should NEVER be administered intravenously 1
- Due to the use of lidocaine HCl as a diluent, ertapenem administered intramuscularly is contraindicated in patients with a known hypersensitivity to local anesthetics of the amide type 1
- For pediatric patients 3 months to 12 years of age, the same reconstitution volume (3.2 mL of 1% lidocaine) should be used, but the dose administered should be 15 mg/kg of body weight (not to exceed 1 g/day) 1
- Discard any unused portion of the reconstituted solution 1
Safety Considerations When Using Lidocaine
- When using lidocaine for reconstitution, be aware of the maximum safe dose limits for lidocaine (7 mg/kg with epinephrine, 4.5 mg/kg without epinephrine in adults) 2
- Avoid using ertapenem with lidocaine in patients who have recently received other local anesthetic interventions, as combining local anesthetics increases risk of toxicity 2
- Intravenous lidocaine should not be started within 4 hours of any nerve or fascial plane block, or infiltration of local anesthetic 2
- Be vigilant for signs of local anesthetic systemic toxicity, which may include circumoral numbness, facial tingling, slurred speech, metallic taste, auditory changes, and hallucinations 2
Clinical Evidence for Intramuscular Administration
- Clinical studies have shown that ertapenem 1 g reconstituted in lidocaine and administered intramuscularly once daily is generally well tolerated 3
- In comparative studies, only 1.1% of patients receiving IM ertapenem (reconstituted with lidocaine) experienced moderate to severe injection site symptoms, compared to 10.0% in a ceftriaxone group 3
- The most common local injection site symptoms are tenderness and pain 3
By following these reconstitution guidelines, you can ensure proper preparation and administration of ertapenem for intramuscular use while minimizing patient discomfort and maintaining drug efficacy.